Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Cyclin-Dependent Kinase Inhibitor 3 (CDKN3) Peptid

CDKN3 Reaktivität: Säugetier Wirt: Synthetic BP, WB, IHC
Produktnummer ABIN937106

Kurzübersicht für Cyclin-Dependent Kinase Inhibitor 3 (CDKN3) Peptid (ABIN937106)

Target

CDKN3 (Cyclin-Dependent Kinase Inhibitor 3 (CDKN3))

Spezies

Säugetier

Quelle

  • 2
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Protein-Typ

    Synthetic

    Sequenz

    CKFKDVRRNV QKDTEELKSC GIQDIFVFCT RGELSKYRVP NLLDLYQQCG

    Produktmerkmale

    A synthetic peptide for use as a blocking control in assays to test for specificity of CDKN3 antibody,
    Alternative Names: CDKN3 control peptide, CDKN3 antibody Blocking Peptide, Anti-CDKN3 Blocking Peptide, Cyclin-Dependent Kinase Inhibitor 3 Blocking Peptide, Cdk2-Associated Dual Specificity Phosphatase Blocking Peptide, CDI1 Blocking Peptide, CIP2 Blocking Peptide, FLJ25787 Blocking Peptide, KAP Blocking Peptide, KAP1 Blocking Peptide, MGC70625 Blocking Peptide
  • Applikationshinweise

    Optimal conditions should be determined by the investigator

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.

    Buffer

    PBS

    Handhabung

    Avoid repeated freeze/thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store at -20 °C long term.
  • Target

    CDKN3 (Cyclin-Dependent Kinase Inhibitor 3 (CDKN3))

    Hintergrund

    The protein encoded by this gene belongs to the dual specificity protein phosphatase family. It was identified as a cyclin-dependent kinase inhibitor, and has been shown to interact with, and dephosphorylate CDK2 kinase, thus prevent the activation of CDK2 kinase. This gene was reported to be deleted, mutated, or overexpressed in several kinds of cancers.

    Molekulargewicht

    23 kDa
Sie sind hier:
Chat with us!